Oruka Therapeutics, Inc.

Historical 13F Holders

Symbol
ORKA
CUSIP
687604108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 687604108 since 12/18/2024, largest first.

Filer % of Class Filed
Fairmount Funds Management LLC 13D/A
19.5% 7/1/2026
Event 7/1/2026
Venrock Healthcare Capital Partners III, L.P. 13G/A
7.4% 8/14/2026
Event 6/30/2026
BlackRock, Inc. 13G 6.6% 1/21/2026
Event 12/31/2025
Capital World Investors 13G 5.6% 8/12/2026
Event 6/30/2026
RTW Investments, LP 13G
5.2% 8/14/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Deep Track Capital, LP 13G/A
4.5% 2/13/2026
Event 12/31/2025
Viking Global Investors LP 13G/A
2.5% 8/14/2026
Event 6/30/2026
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 542 $45.1 k
2026 Q2 265 77.6 M $7.09 B
2026 Q1 190 52.9 M $2.61 B
2025 Q4 146 52.9 M $1.56 B
2025 Q3 111 45.6 M $876 M
2025 Q2 83 34.6 M $387 M
2025 Q1 72 31.8 M $326 M
2024 Q4 67 31.0 M $607 M
2024 Q3 44 24.6 M $604 M